Lisa Lynn Decker - 28 Dec 2023 Form 4 Insider Report for CHIMERIX INC (CMRX)

Role: Director
Signature: /s/ Michael Alrutz, Attorney-In-Fact
Issuer symbol: CMRX
Transactions as of: 28 Dec 2023
Net transactions value: $0
Form type: 4
Filing time: 02 Jan 2024, 11:09:21 UTC
Previous filing: 15 Dec 2023
Next filing: 14 Mar 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CMRX	Stock Option (Right to Buy)	Award	$0	+100,000		$0.000000	100,000	28 Dec 2023	Common Stock	100,000	$0.9200	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One-third of the shares subject to the stock option will vest and become exercisable on December 28, 2024 and the balance of the shares will vest in a series of 24 equal monthly installments thereafter, such that the option is fully vested on December 28, 2026, subject to Reporting Person's Continuous Service (as defined in the Plan) through each such vesting date and will vest in full upon a Change in Control (as defined in the Plan).

Content

One-third of the shares subject to the stock option will vest and become exercisable on December 28, 2024 and the balance of the shares will vest in a series of 24 equal monthly installments thereafter, such that the option is fully vested on December 28, 2026, subject to Reporting Person's Continuous Service (as defined in the Plan) through each such vesting date and will vest in full upon a Change in Control (as defined in the Plan).